Showing results (1651-1660 of 1,768) with videos related to

Sort By:
Pageof 177
Psychopharmacology|March 17, 2022
Ropanicant (SUVN-911), an α4β2 nicotinic acetylcholine receptor antagonist intended for the treatment of depressive disorders: pharmacological, behavioral, and neurochemical characterizationRamakrishna Nirogi, Renny Abraham, Pradeep Jayarajan, et al.
Frontiers in Plant Science|March 30, 2026
Integrating marker-assisted identification and multi-environment trait stability models to select superior rice restorer lines for hybrid breedingShridhar Ragi, Vikram Jeet Singh, Shekharappa Nandakumar, et al.
Indian Journal of Nephrology|July 17, 2026
Retrospective Analysis of the Outcomes of Mycophenolate Therapy in Retarding the Progression of Immunoglobulin A Nephropathy (REMISSION IgA)Chilaka Rajesh, Selvin Sundar Raj Mani, Utkarash Mishra, et al.
Chembiochem : a European Journal of Chemical Biology|March 20, 2015
Hepatocyte-specific delivery of siRNAs conjugated to novel non-nucleosidic trivalent N-acetylgalactosamine elicits robust gene silencing in vivoKallanthottathil G Rajeev, Jayaprakash K Nair, Muthusamy Jayaraman, et al.
Circulation Research|May 7, 2024
Ultrasound Neuromodulation of an Anti-Inflammatory Pathway at the Spleen Improves Experimental Pulmonary HypertensionStefanos Zafeiropoulos, Umair Ahmed, Alexandra Bekiaridou, et al.
Brain Stimulation|October 14, 2022
kHz-frequency electrical stimulation selectively activates small, unmyelinated vagus afferentsYao-Chuan Chang, Umair Ahmed, Naveen Jayaprakash, et al.
Cancer|June 28, 2019
Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trialRobert Haddad, Fernando Concha-Benavente, George Blumenschein, et al.
Forensic Science International|October 21, 2015
Study on the performance of different craniofacial superimposition approaches (II): Best practices proposalS Damas, C Wilkinson, T Kahana, et al.
Molecular Therapy. Methods & Clinical Development|September 2, 2025
Novel transferrin receptor-mediated enzyme replacement therapy efficiently treats myogenic and neurogenic aspects of Pompe disease in miceKelly George, Raquel Riley, Shan Zhou, et al.
Cell Reports|February 2, 2024
H2A.Z histone variants facilitate HDACi-dependent removal of H3.3K27M mutant protein in pediatric high-grade glioma cellsKatarzyna B Leszczynska, Amanda Freitas-Huhtamäki, Chinchu Jayaprakash, et al.
Pageof 177